Skip to main content

Table 2 Tumor retention in patients imaged with 18F-FLT

From: Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents: 18F-FAU, 18F-FMAU, and 18F-FLT

Patient No.

Tumor SUVmean

Tracer flux into tumor (cc/min)

Baseline

Post-treatment

% Change

Baseline

Post-treatment

% Change

1

1.97

1.58

−19.8

0.0271

0.0211

−22.1

2

1.96

2.34

19.4

0.0314

0.0526

67.5

3

4.70

12.80

172.3

0.0217

0.0796

266.8

4

2.27

4.31

89.9

0.0187

0.1090

482.9

5

1.34

1.00

−25.4

0.0267

0.0213

−20.2